Physician profile
Steven Weiner
NPI 1770949893
$679,918.52
in general payments reported to CMS, 2019-2025
12 companies · $70K in 2025
The $70K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113K · 2020: $81K · 2021: $176K · 2022: $106K · 2023: $29K · 2024: $105K · 2025: $70K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Consulting Fee: $96K · Food and Beverage: $3,840 · Travel and Lodging: $2,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102,072.50 |
| Consulting Fee | $95,773.60 |
| Food and Beverage | $3,840.28 |
| Travel and Lodging | $2,136.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $613,947.47 | 2019-2025 | Dysport |
| Clarius Mobile Health Corp. | $23,250.00 | 2021-2025 | |
| Merz North America, INC. | $20,085.52 | 2019-2025 | Xeomin |
| Allergan, INC. | $16,637.61 | 2020-2022 | |
| Lumenis, INC | $4,321.73 | 2019 | |
| Revance Therapeutics, INC. | $687.83 | 2024-2025 | Daxxify |
| Fujifilm Sonosite, INC. | $375.00 | 2020 | |
| Abbvie INC. | $372.26 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $123.13 | 2019 | |
| Apyx Medical Corporation | $70.48 | 2019 | |
| Bausch Health US, LLC | $24.72 | 2025 | Aplenzin, Wellbutrin |
| Tela Bio, INC. | $22.77 | 2024 | Ovitex 2s |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Weiner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.